Xellia Pharmaceuticals

Email address and contacts

Xellia Pharmaceuticals company description

Xellia Pharmaceuticals (“Xellia”) is a specialty pharmaceutical company developing, manufacturing, and commercializing anti-infective treatments against serious and often life-threatening bacterial and fungal infections. The corporate headquarters is located in Copenhagen, Denmark and Xellia has a global footprint with R&D, manufacturing and commercial operations across Europe, Asia, the Middle East and North America. Xellia’s four manufacturing facilities are located in China, Denmark, Hungary and in the U.S. With over 115 years of experience and with more than 1700 employees, Xellia is a world-leading trusted supplier of several important established anti-infective drugs. Supplying products to more than 70 countries worldwide and with more than 500 customers internationally, Xellia is the leading supplier of important anti-infectives vancomycin and colistimethate sodium (CMS). Xellia’s purpose is to save lives by leading the fight against infections. We work to achieve our goal by prioritizing the patient and through providing a strong and resilient supply of critical anti-infectives. Continuing the Company’s evolution, Xellia Pharmaceuticals focuses its R&D investments within inhalable and injectable product technologies, generating an innovative pipeline of value-added anti-infective medicines intended to enhance patient care, providing convenience and ease of use for healthcare professionals.

Key Employees

?
************
Subject Matter Expert
Find Email
E
Eirik Bergum
ingeniør
B
Bjørn Reitstøen
Prosjektleder
H
Helle Olsen
Senior Research Scientist
A
Amy Hammar
Global Technical Support Specialist
A
Andrea Wardeiner
Scientist, On Market Products
S
Sushant Kolipaka
Process Engineer
Sign up to open these and 5 more emails in Xellia Pharmaceuticals
Message error line

Xellia Pharmaceuticals competitors and alternatives

Endo
Pharmaceuticals
1399 employees
Angelini Pharma
Pharmaceuticals
1331 employees
Eurofins Environment Testing America
Pharmaceuticals
1304 employees
Santen
Pharmaceuticals
1245 employees
Taro Pharmaceuticals
Pharmaceuticals
1229 employees
Sanovel İlaç
Pharmaceuticals
1207 employees
View all competitors

Recently updated team members of Xellia Pharmaceuticals

C
Chris FitzGerald
Senior Consultant for Sequence, Inc.
D
David Gustafson
Director Supply Chain and Demand Planning North America
K
Kim Rohn
Director, Commercial Quality
M
Matt Henderson
Sr. Director of National Accounts, Trade Relations & Inside Sales
G
Graham Vonder Haar
Director, B2B Key Account Management
A
Anne-Mie Marker
production planner
View all employees

GetProspect Email Finder

Retrieve thousands of email addresses in single click without leaving your current tab. Download for free now!

100 Free emails every month

Add to Chrome

400+ reviews 50,000+ users

Ready to get started?

Try GetProspect email finder for free, and explore all the tools you need to scale your business

Real data
No credit card needed
Leave any time
Find Emails